126 related articles for article (PubMed ID: 31862557)
1. Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States.
Roehler DR; Hoots BE; Vivolo-Kantor AM
Drug Alcohol Depend; 2020 Feb; 207():107810. PubMed ID: 31862557
[TBL] [Abstract][Full Text] [Related]
2. Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.
Vivolo-Kantor AM; Seth P; Gladden RM; Mattson CL; Baldwin GT; Kite-Powell A; Coletta MA
MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(9):279-285. PubMed ID: 29518069
[TBL] [Abstract][Full Text] [Related]
3. Suspected Nonfatal Drug-Related Overdoses Among Youth in the US: 2016-2019.
Roehler DR; Olsen EO; Mustaquim D; Vivolo-Kantor AM
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33288728
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.
Anderson SAR; Oprescu AM; Calello DP; Monte A; Dayan PS; Hurd YL; Manini AF;
Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31285395
[TBL] [Abstract][Full Text] [Related]
5. Trends in U.S. emergency department visits for opioid overdose, 1993-2010.
Hasegawa K; Espinola JA; Brown DF; Camargo CA
Pain Med; 2014 Oct; 15(10):1765-70. PubMed ID: 25139712
[TBL] [Abstract][Full Text] [Related]
6. Using the Centers for Disease Control and Prevention's National Syndromic Surveillance Program Data to Monitor Trends in US Emergency Department Visits for Firearm Injuries, 2018 to 2019.
Zwald ML; Holland KM; Bowen DA; Simon TR; Dahlberg LL; Stein Z; Idaikkadar N; Mercy JA
Ann Emerg Med; 2022 May; 79(5):465-473. PubMed ID: 35277293
[TBL] [Abstract][Full Text] [Related]
7. Respiratory failure in confirmed synthetic cannabinoid overdose.
Manini AF; Krotulski AJ; Schimmel J; Allen L; Hurd YL; Richardson LD; Vidal K; Logan BK
Clin Toxicol (Phila); 2022 Apr; 60(4):524-526. PubMed ID: 34499005
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Sexual Violence Trends in Emergency Department Visits Using Syndromic Data From the National Syndromic Surveillance Program-United States, January 2017-December 2019.
D'Inverno AS; Idaikkadar N; Houry D
Am J Public Health; 2021 Mar; 111(3):485-493. PubMed ID: 33476240
[No Abstract] [Full Text] [Related]
9. Suspected Heroin Overdoses in US Emergency Departments, 2017-2018.
Vivolo-Kantor AM; Hoots B; David F; Gladden RM
Am J Public Health; 2019 Jul; 109(7):1022-1024. PubMed ID: 31095410
[TBL] [Abstract][Full Text] [Related]
10. Suspected Nonfatal Cocaine-Involved Overdoses Overall and With Co-involvement of Opioids.
Scholl L; Liu S; Pickens CM
J Public Health Manag Pract; 2023 May-Jun 01; 29(3):392-402. PubMed ID: 36867655
[TBL] [Abstract][Full Text] [Related]
11. Trends in Emergency Department Use by Rural and Urban Populations in the United States.
Greenwood-Ericksen MB; Kocher K
JAMA Netw Open; 2019 Apr; 2(4):e191919. PubMed ID: 30977849
[TBL] [Abstract][Full Text] [Related]
12. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and synthetic cannabinoids as a cause of death: Trends and their healthcare implications.
Suriaga A; Tappen RM; Aston ER; Chiang-Hanisko L; Newman D
J Nurs Scholarsh; 2023 May; 55(3):623-636. PubMed ID: 36250599
[TBL] [Abstract][Full Text] [Related]
14. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
[TBL] [Abstract][Full Text] [Related]
15. Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic.
Holland KM; Jones C; Vivolo-Kantor AM; Idaikkadar N; Zwald M; Hoots B; Yard E; D'Inverno A; Swedo E; Chen MS; Petrosky E; Board A; Martinez P; Stone DM; Law R; Coletta MA; Adjemian J; Thomas C; Puddy RW; Peacock G; Dowling NF; Houry D
JAMA Psychiatry; 2021 Apr; 78(4):372-379. PubMed ID: 33533876
[TBL] [Abstract][Full Text] [Related]
16. Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006-2018.
Roehler DR; Hoots BE; Holland KM; Baldwin GT; Vivolo-Kantor AM
Drug Alcohol Depend; 2022 Mar; 232():109288. PubMed ID: 35033959
[TBL] [Abstract][Full Text] [Related]
17. Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015.
Riederer AM; Campleman SL; Carlson RG; Boyer EW; Manini AF; Wax PM; Brent JA;
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(27):692-5. PubMed ID: 27413997
[TBL] [Abstract][Full Text] [Related]
18. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.
Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA
Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050
[TBL] [Abstract][Full Text] [Related]
19. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
[No Abstract] [Full Text] [Related]
20. Development and Validation of a Syndrome Definition for Suspected Nonfatal Unintentional/Undetermined Intent Stimulant-Involved Overdoses.
Pickens CM; Scholl L; Liu S; Smith H; Snodgrass S
Public Health Rep; 2022; 137(6):1079-1090. PubMed ID: 34727510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
